Abstract
We report here the complete genome sequence of a metronidazole-resistant Helicobacter pylori strain (METr). The METr strain was obtained under exposure of H. pylori 26695 on agar plates with low metronidazole concentrations. The genome data provide insight into the genomic changes of H. pylori under selection by metronidazole in vitro.
GENOME ANNOUNCEMENT
Helicobacter pylori is a spiral Gram-negative bacterium that infects more than half of the world’s population and is a major cause of chronic gastritis, peptic ulcer diseases, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (MALT) (1, 2). The eradication of H. pylori not only improves peptic ulcer healing but also prevents its recurrence and reduces the risk of developing gastric cancer (3–6). Metronidazole has been widely used in combination with therapies, such as metronidazole-based triple therapy, concomitant therapy, and bismuth-containing quadruple therapy, to eradicate this bacterium (6–8). Although treatment success depends on several factors, such as smoking status and patient compliance, antibiotic resistance is the major cause (9–11). However, along with clarithromycin resistance, resistance to metronidazole has arisen independently and is becoming increasingly common (12, 13).
In the present report, we announce the genome sequence of a metronidazole (MET)-resistant (METr) H. pylori strain obtained in vitro. The genome of the strain provides insight into the genomic changes of H. pylori under MET selection.
The METr strain was obtained under the exposure to a low concentration of MET in vitro (up to 16.0 µg/ml MET in an agar plate), and whole-genome sequencing was performed using 90-base paired-end reads on the Illumina HiSeq 2000 genome sequencer (Illumina, Inc., San Diego, CA). The whole-genome sequence of the strain was reconstructed by mapping the short-read sequences on the genome of H. pylori 26695 (GenBank accession no. NC_000915) using CLC Genomics Workbench version 4.0 (CLC bio, Aarhus, Denmark). The length of 26695-1MET genome is 1,667,302 bp, with a coverage depth of 680×. The G+C content of this strain is 38.87%.
Three mutations in 3 genes were found in the H. pylori METr strain, including the mutations in the rdxA (hp0954) and frxA (hp0642) genes (14). The new mutation (G37T) was found in the gene rpsU (hp0562).
Nucleotide sequence accession number.
The genome sequence of the metronidazole-resistant H. pylori strain (26695-1MET) was deposited at GenBank under the accession no. CP010436.
ACKNOWLEDGMENTS
This study was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (25293104, 24659200, and 24406015) (to Y.Y.), the Special Coordination Funds for Promoting Science and Technology from the MEXT of Japan (to Y.Y.), and National Institutes of Health grants DK62813 (to Y.Y.) and GM94053 (to D.H.K.). T.T.B. is a doctoral student supported by the Japanese Government (Monbukagakusho: MEXT) Scholarship Program for 2010.
Footnotes
Citation Binh TT, Suzuki R, Kwon DH, Yamaoka Y. 2015. Complete genome sequence of a metronidazole-resistant Helicobacter pylori strain. Genome Announc 3(2):e00051-15. doi:10.1128/genomeA.00051-15.
REFERENCES
- 1.Peek RM Jr, Blaser MJ. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2:28–37. doi: 10.1038/nrc703. [DOI] [PubMed] [Google Scholar]
- 2.Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N Engl J Med 347:1175–1186. doi: 10.1056/NEJMra020542. [DOI] [PubMed] [Google Scholar]
- 3.Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung JJ, Li AK. 1994. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 343:508–510. doi: 10.1016/S0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
- 4.Shiota S, Yamaoka Y. 2010. Management of Helicobacter pylori. F1000 Med Rep 2:20. doi: 10.3410/M2-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. 2007. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 25:805–812. doi: 10.1111/j.1365-2036.2007.03268.x. [DOI] [PubMed] [Google Scholar]
- 6.Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. 2007. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56:772–781. doi: 10.1136/gut.2006.101634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mégraud F, Lamouliatte H. 2003. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 17:1333–1343. doi: 10.1046/j.1365-2036.2003.01592.x. [DOI] [PubMed] [Google Scholar]
- 8.Graham DY, Fischbach L. 2010. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59:1143–1153. doi: 10.1136/gut.2009.192757. [DOI] [PubMed] [Google Scholar]
- 9.Jenks PJ. 2002. Causes of failure of eradication of Helicobacter pylori. BMJ 325:3–4. doi: 10.1136/bmj.325.7354.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Qasim A, O’Morain CA. 2002. Review article: treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther 16(Suppl 1):24–30. doi: 10.1046/j.1365-2036.2002.0160s1024.x. [DOI] [PubMed] [Google Scholar]
- 11.Suzuki T, Matsuo K, Ito H, Sawaki A, Hirose K, Wakai K, Sato S, Nakamura T, Yamao K, Ueda R, Tajima K. 2006. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 119:217–224. doi: 10.1016/j.amjmed.2005.10.003. [DOI] [PubMed] [Google Scholar]
- 12.Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference . 2009. Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 24:1587–1600. doi: 10.1111/j.1440-1746.2009.05982.x. [DOI] [PubMed] [Google Scholar]
- 13.De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, Ierardi E, Zullo A. 2010. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 19:409–414. [PubMed] [Google Scholar]
- 14.Francesco VD, Zullo A, Hassan C, Giorgio F, Rosania R, Ierardi E. 2011. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J Gastrointest Pathophysiol 2:35–41. doi: 10.4291/wjgp.v2.i3.35. [DOI] [PMC free article] [PubMed] [Google Scholar]